tm logo
AQUESTIVE
REGISTERED

on 19 Nov 2019

Last Applicant/ Owned by

AQUESTIVE THERAPEUTICS INC. A DELAWARE CORPORATION

30 Technology DriveWarren, New Jersey 07059

US

Serial Number

1759227 filed on 11th Dec 2015

Registration Number

TMA1063679 registered on 19th Nov 2019

Registration expiry Date

19th Nov 2029

Correspondent Address

(RIEL PROFESSIONAL CORPORATION)411 Roosevelt Avenue, Suite 206Ottawa

ONTARIO

CA

K2A3X9

AQUESTIVE

Trademark usage description

drug delivery agents in the form of oral soluble film, sublingual film, transmucosal film, softgels, tablets, capsules, and liquids that facilitate th Read More

Classification Information


Class [005]
Pharmaceutical preparations for the treatment of: neurological diseases and disorders, namely cerebrovascular accident (stroke), Parkinson's disease, multiple sclerosis, myasthenia gravis, Huntington's disease, attention deficit disorder, attention deficit hyperactivity disorder, epilepsy, Lennox-Gastaut syndrome, amyotrophic lateral sclerosis, narcolepsy, fatigue, opioid addiction, Alzheimer's disease, cardiopulmonary diseases and disorders, metabolic diseases and disorders, namely diabetes, hypoglycaemia, gout, osteoarthritis, muscular dystrophy, anemia, gastro-intestinal disorders, nausea, vomiting, emesis, endocrine diseases and disorders, namely growth and thyroid disorders, hormonal disorders, myocardial infarction, diarrhoea, acromegaly, carcinoid syndrome, genitourinary diseases and disorders, namely urological diseases, infertility, sexually transmitted diseases, inflammatory pelvic diseases, erectile dysfunction, hypertension, pulmonary hypertension, gastroparesis, hyperphosphataemia, benign prostatic hyperplasia, gastrointestinal diseases and disorders, oncological diseases and disorders, autoimmune diseases and disorders, inflammatory diseases and disorders namely inflammatory immune system response arising from infection or biological, chemical, and physical traumas, pain diseases and disorders, respiratory diseases and disorders, hormonal diseases and disorders, namely corticosteroids, hormone replacement therapy preparations, oral contraceptives, thyroid hormone preparations, psychiatric diseases and disorders, namely anxiety, panic attacks, bipolar disorders, schizophrenia, addiction, personality disorders, obsessive compulsive disorder; Pharmaceutical preparations for the treatment of diabetes; Pharmaceutical preparations for the prevention and treatment of sexual dysfunction; Pharmaceutical preparations for the treatment of diseases and disorders of the cardiovascular system, hypertension, and pulmonary arterial hypertension; Pharmaceutical preparations for the treatment of benign prostatic hyperplasia; Pharmaceutical preparations for the prevention and treatment of migraine, tension, and cluster headaches; Pharmaceutical preparations for the treatment of epilepsy; Pharmaceutical preparations for the prevention and treatment of anaphylaxis, asthma, and allergic reactions; Pharmaceutical preparations for the treatment of HIV, AIDS, and post-treatment nausea and vomiting.


Classification kind code

11

Mark Details


Serial Number

1759227

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 15
on 05th Apr 2019
Correspondence Created
Submitted for opposition 12
on 03rd Oct 2018
Extension of Time
Submitted for opposition 135
on 15th Mar 2018
Amendment to Application
Submitted for opposition 15
on 04th Dec 2017
Correspondence Created
Submitted for opposition 15
on 03rd Feb 2017
Correspondence Created
Submitted for opposition 22
on 17th May 2016
Search Recorded
Submitted for opposition 20
on 17th May 2016
Examiner's First Report
Submitted for opposition 31
on 17th Dec 2015
Formalized
Submitted for opposition 1
on 14th Dec 2015
Created
Submitted for opposition 30
on 11th Dec 2015
Filed